THE GRASS IS GREENER SOMEWHERE: PROTECTING PRIVACY RIGHTS OF MEDICAL CANNABIS PATIENTS IN THE WORKPLACE by West, Benjamin
Chicago-Kent Law Review 
Volume 95 
Issue 3 Reviving the American Jury Article 8 
4-27-2021 
THE GRASS IS GREENER SOMEWHERE: PROTECTING PRIVACY 
RIGHTS OF MEDICAL CANNABIS PATIENTS IN THE WORKPLACE 
Benjamin West 
Chicago-Kent College of Law 
Follow this and additional works at: https://scholarship.kentlaw.iit.edu/cklawreview 
 Part of the Food and Drug Law Commons, and the Other Law Commons 
Recommended Citation 
Benjamin West, THE GRASS IS GREENER SOMEWHERE: PROTECTING PRIVACY RIGHTS OF MEDICAL 
CANNABIS PATIENTS IN THE WORKPLACE, 95 Chi.-Kent L. Rev. 751 (2021). 
Available at: https://scholarship.kentlaw.iit.edu/cklawreview/vol95/iss3/8 
This Article is brought to you for free and open access by Scholarly Commons @ IIT Chicago-Kent College of Law. 
It has been accepted for inclusion in Chicago-Kent Law Review by an authorized editor of Scholarly Commons @ IIT 
Chicago-Kent College of Law. For more information, please contact jwenger@kentlaw.iit.edu, 
ebarney@kentlaw.iit.edu. 
751 
THE GRASS IS GREENER SOMEWHERE: PROTECTING 




For many companies, recent strong economic growth has resulted in 
profit windfalls and increased valuation.1 The United States unemployment 
rate as of August 2019 continues to remain at a “near-historic low.”2 How-
ever, accompanying low unemployment has resulted in a tightened job 
market throughout many parts of the country creating challenges for busi-
nesses and employers seeking to hire qualified employees.3 This often tax-
ing search for new, qualified employees is further complicated by the fact 
that many otherwise qualified applicants are disqualified due to testing 
positive for cannabis use as part of a company’s requisite pre-employment 
drug test.4 While a dearth of qualified employees is challenging for em-
ployers in a hiring market, a continued strict adherence to “zero-tolerance” 
policies dictating pre-employment or other cannabis drug testing as part of 
an employment relationship is especially problematic for medical cannabis 
patients regardless of whether the economy is good or not. Medical canna-
bis patients, even those that reside in states that have legalized cannabis for 
medical or recreational use, often face a difficult choice when seeking em-
ployment, either (1) cease using cannabis, or (2) find employment with an 
employer that does not test for cannabis use. Those caught cheating on 
employer-required drug tests by using substances such as synthetic urine 
 J.D., May 2019, Chicago-Kent College of Law, Illinois Institute of Technology. 
 1.  See Kathryn Kranhold, Twice as Many Companies Paying Zero Taxes under Trump Tax Plan,
NBC NEWS (Apr. 11, 2019), https://www.nbcnews.com/business/taxes/twice-many-companies-paying-
zero-taxes-under-trump-tax-plan-n993046 [http://perma.cc/ASD3-ATM9]. 
 2.  COUNCIL OF ECON. ADVISORS, U.S. Unemployment Rate Remains at Near-Historic Low of 
3.7 Percent; African-American Unemployment Rate Hits New Series Low,
https://www.whitehouse.gov/articles/u-s-unemployment-rate-remains-at-near-historic-low-of-3-7-
percent-african-american-unemployment-rate-hits-new-series-low [http://perma.cc/629E-2TZB] (last 
visited Mar. 12, 2020). 
 3.  See Christopher Rugaber, More Businesses Are Mellowing Out Over Hiring Pot Smokers, AP 
NEWS (May 2, 2018), https://apnews.com/7e7877c08d7e43418c08738a67bf61a4 
[http://perma.cc/9XLH-9GFA]. 
 4.  See id.
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may even risk felony criminal charges in some states.5 These choices are 
unreasonable, especially where there is existing state law legalizing canna-
bis for medical or recreational use, taking into consideration that drug-
testing should be acceptable in limited circumstances, such as for “safety-
sensitive” occupations like operating heavy machinery or flying an air-
plane.6
Cannabis use among the American workforce, whether for medical or 
recreational purposes, is higher than it has been in over a decade.7 Some 
companies and employers are voluntarily taking a more relaxed approach 
to zero-tolerance drug policies by excluding cannabis from their drug test-
ing protocol, yet others continue to screen for cannabis use even though 
traditional screening methods, such as urinalysis, are overbroad, in that 
such methods may evidence cannabis use long after the impairing effects of 
cannabis have ceased.8 As more states continue to legalize cannabis for 
medical and recreational use, some states and localities have robust em-
ployee privacy protections regarding employer drug testing,9 while others 
could do more to protect medical cannabis patients from adverse employ-
ment actions resulting from job-related cannabis drug-testing.10 This note 
posits the argument that states and localities should better protect medical 
and privacy rights of certified cannabis patients by maintaining a reasona-
ble balance between employer concerns related to occupational safety and 
the rights of employees who should be free from any undue burden of 
choosing between medicine or employment. 
Part I of this note considers cannabis in a legal and historical frame-
work. Given the continuously growing favorable medical and public opin-
ions regarding continued state-by-state legalization and conflicting federal 
 5.  See Aditi Shrikant, The Thriving, Legally Questionable Market for Synthetic Urine, VOX 




 6.  See Alonzo Martinez, Up In Smoke: Pre-Employment Marijuana Testing Goes Poof In NYC 
And Nevada, FORBES (Aug. 16, 2019), https://www.forbes.com/sites/alonzomartinez/2019/08/16/up-in-
smoke-pre-employment-marijuana-testing-goes-poof-in-nyc-and-nevada/#3f898ac438ec 
[http://perma.cc/73BA-K8VY]. 
 7.  Shamane Mills, Drug Use By Workers, Job Applicants At Highest Rate In More Than A 
Decade, WISCONSIN PUB. RADIO NEWS (May 14, 2018), https://www.wpr.org/drug-use-workers-job-
applicants-%C2%A0highest-rate-more-decade [http://perma.cc/Q3ZS-5Q8R]. 
 8.  See id.
 9.  See Martinez, supra note 6. 
 10.  In Illinois, for example, employers are still allowed to drug test and take adverse employment 
actions against employees for failing. See Cannabis Regulation and Tax Act, H.B. 1438, 2019 Gen. 
Assemb. 101st Sess. (Ill. 2019) § 10-50(a), https://www2.illinois.gov/IISNews/19996-
Adult_Use_Cannabis_Legislation.pdf [http://perma.cc/G5NZ-YLUQ].  
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officials’ views apropos of the plant’s legal and medicinal-value status, 
why cannabis drug testing is still omnipresent throughout much of the 
American employment landscape seems little more than residue of anti-
cannabis policy born of harshly anti-cannabis polity. Cannabis has a convo-
luted legal legacy in the United States and continues to remain in a legal 
gray area even as individual states have been legalizing cannabis for medi-
cal use for over two decades,11 and with several states legalizing recrea-
tional use beginning in 2012.12 Only a handful of states continue to prohibit 
cannabis for any medical use.13 Yet, even as states trend toward legaliza-
tion, cannabis continues to be relegated to the harshest prohibition status 
under the federal Controlled Substances Act (“CSA”) drug-scheduling 
regime.14
The conflict between states legalizing cannabis and the federal CSA is 
a source of frustration for many who attempt to navigate cannabis law: 
Because federal law trumps state law and because federal law is adamantly 
prohibitive, there is little uniformity. This means that a person may legally 
possess cannabis in one state but not in a neighboring state. Criminal penal-
ties for trafficking and even simple possession of cannabis can be harsh in 
some states,15 while other states, such as Illinois, are expunging certain 
cannabis convictions for past offenders as cannabis is legalized in the state 
for recreational use.16 At the federal level however, there appears little 
sympathy for those with cannabis convictions. For example, having a con-
 11.  California was the first state to legalize cannabis for medical use in 1996, with most other 
states following suit. See Adia Robinson, Where States Stand on Legalizing Recreational and Medical 
Marijuana, ABC NEWS (July 14, 2018, 3:14 AM), https://abcnews.go.com/Politics/states-stand-
legalizing-recreational-medical-marijuana/story?id=56466308 [http://perma.cc/6KKY-33CN]. 
 12.  See id. In 2012, Washington and Colorado were the first two states to legalize cannabis for 
adult-use, followed by Alaska and Oregon in 2014, California, Nevada, Maine and Massachusetts in 
2016. Vermont legalized recreational cannabis as of 2019.  
 13.  Sean Williams, The Only 4 States that Completely Can THC and CBD, THE MOTLEY FOOL
(April 22, 2018, 9:36 AM), https://www.fool.com/investing/2018/04/22/the-only-4-states-that-
completely-ban-thc-and-cbd.aspx [http://perma.cc/5629-7SYQ]. 
 14.  21 U.S.C. §812(b)(1) (2006), available at https://www.govinfo.gov/content/pkg/USCODE-
2011-title21/pdf/USCODE-2011-title21-chap13-subchapI-partB-sec812.pdf [https://perma.cc/99DT-
DUR3]. See Drug Scheduling, DEA, https://www.dea.gov/drug-scheduling [http://perma.cc/7NLG-
4PFH] (last visited Mar. 12, 2020). For a more in-depth analysis of the federal prohibition status of 
cannabis, see David R. Katner, Up In Smoke: Removing Marijuana from Schedule I, 27 B.U. PUB. INT.
L.J. 167, 174-78 (2018).  
 15.  In Idaho, for example, penalties for simple possession can include up to a year of incarcera-
tion. See Elisabeth Garber-Paul & Tana Ganeva, The State-by-State Guide to Weed in America,
ROLLING STONE (April 20, 2018, 9:02 PM), https://www.rollingstone.com/culture/culture-news/the-
state-by-state-guide-to-weed-in-america-627968/ [http://perma.cc/M7LD-ZNT3]  
 16.  See Cannabis Regulation and Tax Act, H.B. 1438, 2019 Gen. Assemb. 101st Sess. (Ill. 2019) 
§ 10-50(a), https://www2.illinois.gov/IISNews/19996-Adult_Use_Cannabis_Legislation.pdf 
[http://perma.cc/G5NZ-YLUQ].  
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viction for simple cannabis possession can deny offenders access to im-
portant federal programs like student aid.17
A growing issue in states that have legalized medical cannabis, or may 
do so in the future, concerns employment issues, such as whether medically 
certified cannabis patients who are otherwise legally permitted to consume 
and purchase cannabis under state law should be protected against adverse 
employment actions based solely on employer-mandated cannabis drug-
testing results. Part II of this note considers Coats v. Dish Network18 and 
similar court decisions potentially affecting medical cannabis patients. 
Although cannabis may be legal to purchase and consume for medical and 
recreational use in many states, medical cannabis patients are not necessari-
ly exempt from employer-mandated drug testing, even with a valid state 
medical cannabis certification.19 As one recent state court case has indicat-
ed,20 if state laws are not clear on medical cannabis use as related to em-
ployment,21 those who continue to consume medical cannabis may risk 
foregoing employment opportunities or losing a job because of a drug test. 
Part III of this note examines a sample of state laws that attempt to 
protect employees from adverse employment actions based on drug-testing 
alone. Part III also examines a sample of recent court decisions indicating 
cannabis users may be protected in certain circumstances, showing further 
legislation is likely necessary to achieve alternative outcomes. Some states 
have recently passed legislation protecting employees against adverse em-
ployment actions due to failing a drug test.22 Even though a good deal of 
current state legislation has yet to be tested in the courts, states that provide 
clear rules and guidelines regarding employment drug testing are more 
likely to provide robust employee privacy protections.23 Modifying the at-
will employment standard may be an alternative to cannabis legislation in 
providing a path toward broadly protecting employee privacy rights, but is 
politically dubious. Balanced and unambiguous cannabis laws that eschew 
 17.  Betsy Mayotte, Drug Convictions Can Send Financial Aid Up in Smoke, U.S. NEWS (April 
15, 2015), https://www.usnews.com/education/blogs/student-loan-ranger/2015/04/15/drug-convictions-
can-send-financial-aid-up-in-smoke [http://perma.cc/6HKD-D4SE]. 
 18.  Coats v. Dish Network, LLC, 350 P.3d 849 (Colo. 2015). 
 19.  But see Katherine M. DiCicco & Kathryn J. Russo, New Jersey’s Amended Medical Marijua-
na Law Provides Job Protections and Includes Drug Testing Procedures, DRUG & ALCOHOL TESTING
L. ADVISOR (July 12, 2019), https://www.drugtestlawadvisor.com/2019/07/new-jerseys-amended-
medical-marijuana-law-provides-job-protections-and-includes-drug-testing-procedures/ 
[http://perma.cc/B7L4-A7UW]. 
 20.  See 350 P.3d at 853. 
 21.  See Coats v. Dish Network, LLC, 350 P.3d 849 (Colo. 2015). 
 22.  See DiCicco & Russo, supra note 19. 
 23.  See id.
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most employment drug testing are likely a better option for protecting em-
ployee privacy rights and may serve as models for other states and locali-
ties where cannabis is legal.24
This note presents the argument that, considering the federal govern-
ment’s intransigence regarding rescheduling or de-scheduling cannabis and 
the resulting legal confusion, individual states that proceed to legalize can-
nabis in one form or another should concurrently move forward with craft-
ing legislation that ensures privacy rights of employees and protection from 
adverse employment actions based on drug testing, specifically employees 
who are state-certified medical cannabis patients. Achieving a balance that 
protects privacy rights of employees and addresses concerns of employers, 
such as maintaining a safe working environment, is perhaps politically 
fraught, but can be achieved most effectively through effective and fair 
legislation. While states legalizing cannabis may attempt to strive for bal-
ance in the employment relationship, providing adequate protections to 
medical cannabis patients in particular should be of preeminent concern. 
Illinois is a prime example of a state that has legalized cannabis for 
recreational and expanded medical use but does not necessarily prevent 
employers from drug-testing medical cannabis patients as part of a zero-
tolerance drug policy. Nor does the new law, the Cannabis Regulation and 
Tax Act (“CRTA”), prevent Illinois employers from taking adverse em-
ployment actions against any prospective or current employee for medical 
cannabis use, regardless of the type of job.25 Even Illinois-certified medical 
cannabis patients who never use cannabis while at work continue to be at 
risk of being subjected to cannabis drug-testing as a condition to obtaining 
or maintaining existing employment since employers may generally con-
tinue to use overbroad drug testing methods as part of their employment 
policy.26 In order to promote a fair employment relationship balance with 
regards to zero-tolerance drug policies and employee privacy rights, the 
Illinois state legislature should amend the CRTA that better protects the 
privacy, medical and employment rights of Illinois state-certified medical 
cannabis patients. States similarly situated should likewise amend existing 
laws and those yet to legalize cannabis should consider drafting employee 
privacy protections into any future cannabis legislation. 
 24.  As of January 2020, employers will also be limited in pre-employment drug testing for can-
nabis in Nevada and New York City. See Martinez, supra note 6. 
 25.  There are a few exceptions, such as that policies must be “reasonable” and “nondiscriminato-
ry.” Cannabis Regulation and Tax Act, H.B. 1438, 2019 Gen. Assemb. 101st Sess. (Ill. 2019) § 10-
50(a), https://www2.illinois.gov/IISNews/19996-Adult_Use_Cannabis_Legislation.pdf 
[http://perma.cc/G5NZ-YLUQ]. 
26.  See id.
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I. THE CONVOLUTED LEGAL LEGACY OF CANNABIS
A. Legal Treatment of Cannabis Pre-1970 
For most of human existence, there has been no regulation on or pro-
hibition of cannabis.27 Recent archaeological evidence reveals that humans 
were using cannabis in smokable form as early as 2,500 years ago in Chi-
na.28 The cannabis plant has been utilized by Americans since before the 
time of the founding fathers, with many prominent early-American figures 
known or believed to have either produced or traded the plant in one form 
or another.29 Hemp, the stalk portion of the cannabis plant, was used by 
early settlers to produce valuable commodities such as paper, clothing, and 
rope.30 The flower of the cannabis plant, known to contain the most con-
centrated amount of the psychoactive compound, tetrahydrocannabinol,31
was prescribed widely by physicians in the nineteenth century and was 
viewed as medically beneficial for a range of ailments.32 Cannabis has been 
used and cultivated for thousands of years, as cannabis advocate, Jack Her-
er, notes in his influential book, The Emperor Wears No Clothes: 
From at least the 27th to 7th century B.C. up until this century, cannabis 
was incorporated into virtually all the cultures of the Middle East, Asia 
Minor, India, China, Japan, Europe, and Africa for its superior fiber, 
medicines, oils, food, and for its meditative, euphoric, and relaxational 
uses. Hemp was one of our ancestors’ most important overall industries, 
along with tool making animal husbandry and farming.33
Although humans have been growing, consuming, and trading canna-
bis for a long period of time with little to no regulation, it has only been 
prohibited by law for a relatively short time. In the United States, the histo-
ry of cannabis prohibition does not begin with a law regarding cannabis at 
all, but rather with a law prohibiting opium in 1875.34 In 1883, due to per-
ceived problematic opium use among certain immigrant populations, Con-
 27.  PETER MCWILLIAMS, AIN’T NOBODY’S BUSINESS IF YOU DO 297 (1996) (However, 
McWilliams notes that cannabis was banned by the early Christian Church during the Inquisition be-
cause it was “associated with paganism”). 
 28.  Joel Achenbach, Archaeologists Find Signs of Ritualized Cannabis use 2,500 years ago in 
China, WASH. POST (June 12, 2019), https://www.washingtonpost.com/science/2019/06/12/ 
archaeologists-find-signs-ritualized-cannabis-use-years-ago-china/ [http://perma.cc/8VRE-PA7V]. 
 29.  See Katner, supra note 14, at 174.   
 30.  Id.
 31.  Better known as “THC,” the main psychoactive compound found in cannabis. See Rae Lland, 
What is THC?, LEAFLY (Dec 2, 2016), https://www.leafly.com/news/cannabis-101/what-is-
tetrahydrocannabinol [http://perma.cc/A6K4-5A37]. 
 32.  See Katner, supra note 14, at 174. 
 33.  JACK HERER, THE EMPEROR WEARS NO CLOTHES 95 (1985). 
 34.  MCWILLIAMS, supra note 27, at 273. 
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gress began heavily taxing opium with the intent to decrease demand.35
Even though Congress’ mission had very limited success, it signaled the 
beginning of a practice of taxation and regulation of what the government 
considers illicit drugs.36
At the beginning of the twentieth century, Congress continued regulat-
ing drugs, passing the Pure Food and Drug Act in 1906 and the Harrison 
Narcotics Act (“HNA”) in 1914.37 The latter of these acts did not actually 
make the referenced drugs illegal, but, like the original opium tax of 1883, 
the HNA specifically taxed importing and distributing opium and coca.38
The results of the HNA were not favorable and resulted in an increase in 
the use of the drugs the government had intended to eliminate.39 In an ef-
fort to stymie this increase, the Federal Narcotics Control Board was estab-
lished in 1922, which subsequently made heroin illegal two years later in 
response to surging heroin use.40
However well-intentioned, government prohibitions failed to stop the 
demand for heroin and the government again reacted by enacting more 
laws. In 1930, it created a new federal agency, the Federal Bureau of Nar-
cotics directed by Commissioner Harry Anslinger.41 Anslinger was particu-
larly known for his intensity and fervor regarding cannabis prohibition and 
was successful in getting most states to enact laws against cannabis by 
1937.42 That same year, Anslinger crafted and introduced the Marijuana 
Tax Act (“MTA”)43 to Congress against the backdrop of a formidable anti-
cannabis propaganda campaign conducted by Anslinger himself.44 Just as 
the HNA attempted to tax opiates and coca, the MTA attempted to tax can-
nabis, with the intent to prohibit cannabis completely.45 The MTA present-
ed a legal impossibility, in that it required a person who wished to engage 
in the transfer of cannabis to register with an official with cannabis in hand 
in order to obtain legal transfer status.46 However, not long after the MTA 
was enacted, every state had implemented its own prohibitions against 
cannabis possession, making it impossible to obtain the requisite legal sta-
 35.  Id.
 36.  Id. at 276. 
 37.  Id.
 38.  Id. at 277. 
 39.  Id.
 40.  Id. at 278. 
 41.  Id.
 42.  Id. at 283. 
 43.  Marihuana Tax Act of 1937, Pub. L. No. 75-238, 50 Stat. 551 (1937). 
 44.  MCWILLIAMS, supra note 27, at 285. 
 45.  Id.
 46.  See generally Marihuana Tax Act of 1937, 50 Stat. 551. 
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tus under federal law without self-incrimination for possession under state 
law.47 It was not until 1969 when the Supreme Court heard Leary v. United 
States that the MTA was finally challenged on constitutional grounds.48
Timothy Leary challenged the Act after having been convicted of transport-
ing and concealing cannabis, claiming that the Act violated the Fifth 
Amendment’s protection against self-incrimination.49 The Court agreed, 
and Leary’s conviction was overturned, spelling the end of the MTA.50
However, the prohibition and regulation of cannabis did not end there. 
B. Legal Treatment of Cannabis Post-1970 
In 1970, in reaction to the Court’s decision in Leary, President Nixon 
signed the Controlled Substances Act (“CSA”) into law.51 Still in effect 
today, The CSA proscribes five “schedules” for substances under federal 
control.52 Schedule I controlled substances are considered the most danger-
ous and are therefore the most restricted, with fewer restrictions for sub-
stances in schedules II-V.53 Despite efforts to change the law,54 cannabis 
continues to be classified as a “[s]chedule I drug . . . with no currently ac-
cepted medical use . . . a high potential for abuse and the potential to create 
severe psychological and/or physical dependence” along with heroin, LSD, 
ecstasy, and peyote.55 While limited scientific research on cannabis was 
conducted when the CSA was signed into law in 1970, research has grown 
considerably and many in the scientific and medical community endorse its 
use to treat a wide range of diseases and ailments.56 Today, the majority of 
 47.  MCWILLIAMS, supra note 27, at 285. 
 48.  395 U.S. 6 (1969). 
 49.  Id.
 50.  Id.
 51.  During the early 1970’s President Nixon claimed Timothy Leary was “the most dangerous 
man in America.” See Bill Minutaglio & Steven L. Davis, The Blood Feud that Launched the War on 
Drugs, POLITICO (Jan. 9, 2018), https://www.politico.com/magazine/story/2018/01/09/richard-nixon-
war-on-drugs-timothy-leary-216264 [http://perma.cc/EKL3-XA74]. 
 52.  See 21 U.S.C. §812(b)(1)-(5) (2006), https://www.govinfo.gov/content/pkg/USCODE-2011-
title21/pdf/USCODE-2011-title21-chap13-subchapI-partB-sec812.pdf [https://perma.cc/99DT-DUR3]. 
See Drug Scheduling, DEA, https://www.dea.gov/drug-scheduling [http://perma.cc/7NLG-4PFH] (last 
visited Mar. 12, 2020). 
 53.  See supra note 52 and accompanying text. 
 54.  See, e.g., States’ Medical Marijuana Patient Protection Act, H.R. 689, 113th Cong. (2013). 
 55.  See Drug Scheduling, supra note 52.  
 56.  See Harvard University, Marijuana: The Latest Scientific Findings and Legalization,
YOUTUBE (April 4, 2017), http://www.youtube.com/watch?v=HvRf_3Bil0A. Cannabis has also been 
shown to alleviate pain in cancer patients and promising studies have shown that cannabis is useful for 
treating patients with Alzheimer’s disease and anorexia. See Vincent Vinciguerra, Terry Moore & 
Eileen Brennan, Inhalation Marijuana as an Antiemetic for Cancer Chemotherapy, 85, N.Y. ST. J.
MED. 525, 525-27 (1988); see generally Ladislav Volicer et al., Effects of Dronabinol on Anorexia and 
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states have recognized the medical value of cannabis by allowing legal 
access to cannabis for medical use in the face of federal prohibition.57
A year after Congress adopted the CSA, Nixon began what was 
known as the “war on drugs” and further escalated the prohibition of can-
nabis in the employment context, requiring many employers to report em-
ployees found to have used illegal drugs while on the job.58 While 
Presidents Ford and Carter “distanced themselves from the drug issue” 
during the latter part of the 1970s,59 President Reagan reignited Nixon’s 
war on drugs in the 1980s, culminating in the Drug-Free Workplace Act of 
1988 which required government employers and others to conduct drug 
testing for their employees.60 Congress also passed the Anti-Drug Abuse 
Act, which established the Office of National Drug Control Policy 
(“ONDCP”), which was tasked with managing federal drug control.61 The 
Reagan era anti-drug policies are cited as being the impetus for all em-
ployment drug testing since.62
In 2005, the Supreme Court, in Gonzales v. Raich, held that the CSA, 
as applied to the medicinal use of cannabis, did not violate the Constitution 
because of Congress’s broad power to regulate cannabis under the Com-
merce Clause.63 The Court reasoned that the Commerce Clause allows 
Congress to regulate local economic activity, that “substantially” affects 
interstate commerce, even where states choose to experiment with legaliz-
ing medical cannabis intended for personal consumption within the state.64
The Court’s decision set a precedent that, as Justice O’Connor noted in 
dissent, “extinguishes that experiment, without any proof that the personal 
cultivation, possession, and use of marijuana for medicinal purposes, if 
Disturbed Behavior in Patients with Alzheimer’s Disease, 12 INT’L J. GERIATRIC PSYCHIATRY 913 
(1997). 
 57.  In Illinois, for example, the Illinois Department of Public Health recognizes an extensive list 
of debilitating conditions that qualify patients for medical cannabis registry, see Illinois Department of 
Public Health, Debilitating Conditions, http://www.dph.illinois.gov/topics-services/prevention-
wellness/medical-cannabis/debilitating-conditions [http://perma.cc/YB2M-HV52] (last visited Mar. 12, 
2020). 
 58.  See generally A. BENAVIE, DRUGS: AMERICA’S HOLY WAR (2012). 
 59.  DAVID BOYUM & PETER REUTER, AN ANALYTIC ASSESSMENT OF U.S. DRUG POLICY 6 
(2005). 
 60.  A. BENAVIE, supra note 58. 
 61.  BOYUM & REUTER, supra note 59, at 7-8. 
 62.  Joe Pinsker, The Pointlessness of the Workplace Drug Test, THE ATLANTIC (June 4, 2015), 
https://www.theatlantic.com/business/archive/2015/06/drug-testing-effectiveness/394850/ 
[http://perma.cc/B7AD-WHJC]. 
 63.  545 U.S. 1, 2 (2005). 
 64.  Id.
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economic activity in the first place, has a substantial effect on interstate 
commerce and is therefore an appropriate subject of federal regulation.”65
Similarly, in U.S. v. Oakland Cannabis Buyers’ Co-op., the Court held 
that there is no exception, medical or otherwise, to the CSA’s prohibition 
against distributing and manufacturing cannabis.66 The Court cited the CSA 
scheduling language regarding cannabis, noting the only “express excep-
tion . . . is available . . . for Government-approved research projects.”67 The 
result of this decision is that there are severely limited options for scientists 
to do extensive research that aligns with the federal restriction.68 Yet, these 
limitations have certainly not slowed the efforts of states that continue ex-
perimenting with various forms of cannabis legalization in the face of fed-
eral prohibition. 
States continued to legalize cannabis in one form or another during the 
Obama era as tension grew over the ongoing strict federal prohibition.69
However, rather than rescheduling cannabis under the CSA, the Depart-
ment of Justice under the Obama administration put forth a policy in the 
form of the “Cole Memo,” which essentially deprioritized criminally pros-
ecuting most cannabis cases.70 The Cole Memo was not a permanent fix to 
the underlying issue over the treatment of cannabis under the CSA, but it 
suggested that where states had made their own laws regarding legalizing 
cannabis, United States Attorneys should not squander resources prosecut-
ing cannabis cases.71 Further efforts were made during the Obama era to 
provide protections for states wishing to implement medical cannabis ac-
cess, but these efforts, such as the Rohrabacher-Farr Amendment limiting 
the Justice Department’s use of federal funding to prosecute state medical 
cannabis programs, were limited.72
Fears of a federal clampdown on cannabis reemerged with the election 
of President Donald Trump in 2016.73 Trump’s former Attorney General, 
Jeff Sessions, went on record to make such absurd statements as “good 
 65.  Id.
 66.  532 U.S. 483, 486 (2001). 
 67.  Id. at 490. 
 68.  But see Will Stone, Researching Medical Marijuana May Soon Get Easier, NPR NEWS (Aug. 
27, 2019), https://www.npr.org/sections/health-shots/2019/08/27/754761944/researching-medical-
marijuana-may-soon-get-a-lot-easier [http://perma.cc/R8RG-K4ZF]. 
 69.  See James Higdon, Jeff Sessions’ Coming War on Legal Marijuana, POLITICO (Dec. 5, 2016), 
http://www.politico.com/magazine/story/2016/12/jeff-sessions-coming-war-on-legal-marijuana-214501 
[http://perma.cc/7X6U-3X8L]. 
 70.  Id.
 71.  Id.
 72.  Id.
 73.  Id.
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people don’t smoke pot.”74 And, though Sessions has since resigned, the 
President appears to continue to support the current federal policy of can-
nabis remaining illegal at the federal level.75 Until the federal government 
conforms with current favorable medical and public opinion regarding 
cannabis legalization and seriously reconsiders the harsh treatment of can-
nabis under federal drug scheduling laws, federal criminal prosecution 
continues to be a potential threat to medical patients, consumers, and the 
growing cannabis industry. 
Given the historically absurd legal treatment of cannabis, the ideal 
course of action going forward would be to remove it from the CSA sched-
uling altogether, so that most criminal cases are no longer pursued, threat-
ened, or prosecuted under any law of the United States. The effect of this 
would lessen the enormous costs associated with its prosecution, abate the 
federal government’s reach when it comes to privacy rights, and legitimize 
the federal government’s authority to prosecute criminal cases that truly 
threaten public safety and security.76 Federal legalization of cannabis may 
have the additional effect of ending most employment-related cannabis 
drug testing if cannabis is no longer considered a controlled substance or 
relegated to Schedule I of the CSA. If an employer’s policy includes testing 
for “illegal” drugs and cannabis is not “illegal” under any law of the United 
States, then companies will likely need to have another justification for 
cannabis testing or join the growing number of others in abandoning testing 
for it altogether.77 In the meantime, states will need to continue their efforts 
in legalizing cannabis on their own and should strive for protecting em-
ployee rights when it comes to drug testing, especially the rights of medical 
cannabis patients. 
II. CANNABIS AND EMPLOYMENT LAW: THE CONUNDRUM FOR 
MEDICAL CANNABIS PATIENTS
For certified medical cannabis patients, criminal prosecution is less of 
a concern since patients are largely protected from criminal prosecution 
under state law. A bigger issue, however, is whether cannabis use will sub-
 74.  Id.
 75.  See Brendan Bures, Trump Administration Doubles Down on Anti-Marijuana Position, CHI.
TRIB. (Feb 21, 2020), https://www.chicagotribune.com/marijuana/sns-tft-trump-anti-marijuana-stance-
20200221-jfdx4urbb5bhrf6ldtfpxleopi-story.html [http://perma.cc] 
 76.  See generally David R. Katner, Up In Smoke: Removing Marijuana from Schedule I, 27 B. U.
PUB. INT. L.J. 167 (2018). 
 77.  See Margot Roosevelt, In The Age of Legal Marijuana, Many Employers Drop ‘Zero Toler-
ance’ Drug Tests, L.A. TIMES (April 12, 2019), https://www.latimes.com/business/la-fi-marijuana-drug-
test-hiring-20190412-story.html [http://perma.cc/CT3C-5HT9]. 
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ject them to an adverse employment action if they test positive for cannabis 
as part of an employer-mandated drug screen, even if the patient/employee 
only consumes cannabis during non-work time. The prospect of applying 
for a new job where drug screening for cannabis remains the employer’s 
status quo is onerous for many medical cannabis patients and presents a 
serious employment obstacle for those patients who wish to continue to use 
their medication. The reason for this is that common drug testing used in 
employment, such as urinalysis, is unfairly and unnecessarily overbroad 
because it tests for cannabis use well beyond any impairment window.78
While drug testing in the employment context typically involves testing for 
a variety of drugs illegal under the CSA, cannabis is by far the most fre-
quent to result in a positive drug test result.79 The main reason for this is 
that, unlike other controlled substances, cannabis remains in the body for a 
relatively long time and can appear on drug tests for many weeks or even 
months after a person has consumed it, resulting in a positive test long after 
any notably impairing effects have worn off.80
Some studies of cannabis eschew the negative effects of such sub-
stances in relation to the ability to function at work while noting that work-
related functionality depends on a number of factors that do not always 
align with each other.81 For example, the dosage and frequency of cannabis 
use can have a major impact on the level of impairment.82 One of the big-
gest concerns for employers is not necessarily whether an employee con-
sumed cannabis weeks or even months ago, but whether they are showing 
up for work intoxicated and unable to function or present an imminent safe-
ty risk.83 Regardless of the disagreement among various studies of the ef-
fect of cannabis on work performance and efficiency, there is a general 
consensus that the intoxicating effects of cannabis only last a few hours,84
 78.  See Mills, supra note 7. 
 79.  Workforce Drug Positivity Climbs to Highest Rate Since 2004, According to New Quest 
Diagnostics Analysis, QUEST DIAGNOSTICS: DRUG TESTING INDEX (Apr. 11, 2019), 
https://www.questdiagnostics.com/home/physicians/health-trends/drug-testing [http://perma.cc/U2KV-
B7WU]. 
 80.  Stacy Hickox, Drug Testing of Medical Marijuana Users in the Workplace: An Inaccurate 
Test of Impairment, 29 HOFSTRA LAB. & EMP. L.J. 273, 299 (2012). 
 81.  See generally Raul Gonzalez et al., Nonacute (Residual) Neuropsychological Effects of 
Cannabis Use: A Qualitative Analysis and Systematic Review, 42 J. CLINICAL PHARMACOLOGY 48S 
(2002). 
 82.  See Harrison G. Pope, Jr. et al., Neuropsychological Performance in Long-Term Cannabis 
Users, 58 ARCHIVES GEN. PSYCHIATRY 909, 915 (2001); CARL L. HART & CHARLES KSIR, DRUGS,
SOCIETY & HUMAN BEHAVIOR 367 (14th ed. 2011). 
 83.  Asam C. Uzialko, Cannabis at Work: How Employers are Reacting to the Legalization of 
Marijuana, BUS. NEWS DAILY (Feb. 1, 2019), https://www.businessnewsdaily.com/9386-legal-
marijuana-employment-practices.html [http://perma.cc/5KXC-7H3X]. 
 84.  See Hickox, supra note 80, at 312. 
2020] PRIVACY RIGHTS F MEDICAL CANNABIS PATIENTS 763 
therefore drug testing that tests for cannabis use beyond working hours is 
unnecessarily overbroad and should be considered obsolete and an inaccu-
rate measure of intoxication.85
Even though states are continuing to legalize cannabis, and a growing 
list of employers are voluntarily abandoning cannabis drug testing,86 there 
are many more employers that continue to freely maintain a “zero-
tolerance” policy for all CSA-prohibited controlled substances, including 
cannabis.87 This is the case even in states that have gone as far as to legal-
ize cannabis for recreational use.88 While certain occupations, such as fly-
ing an aircraft, driving a truck, or using potentially hazardous machinery 
may warrant the extra level of security ostensibly provided by drug testing, 
for most occupations cannabis drug testing is likely unnecessary and inef-
fective, serving only to prop up the profitable drug testing industry. State 
courts will likely continue to weigh in on specific cannabis use and em-
ployment issues as they arise, but as the following cases illustrate, adequate 
and well-drafted legislative protections are the foundation to ensuring fair-
ness and justice in the courts. 
For example, in Ross v. Ragingwire Telecommunications, Inc., the 
California Supreme Court examined whether an employer must provide a 
“reasonable accommodation” for a medical cannabis patient.89 The plain-
tiff, Gary Ross, a former United States Air Force servicemember, was pre-
scribed cannabis for pain resulting from injuries he suffered during his 
 85.  See Eric Westervelt, The Pot Breathalyzer is Here. Maybe, NPR (Aug. 4, 2018), 
https://www.npr.org/2018/08/04/634992695/the-pot-breathalyzer-is-here-maybe 
[http://perma.cc/M8NX-WCE5]. Several startup technology companies have developed what they and 
many in law enforcement herald as an innovative solution to the problem of overbreadth in traditional 
drug testing: a breathalyzer device that detects cannabis use within an approximately two-hour window 
after consumption, id. However, such technology may be problematic when applied in the employment 
context, exacerbating existing privacy issues regarding employment cannabis drug testing due to tech-
nological limitations and procedural privacy concerns. Cannabis breathalyzer testing may hold great 
promise for employers, as it would eliminate the need for relying on traditionally overbroad drug 
screening methods, like urinalysis. However, the cannabis breathalyzer is currently only in the pre-
production stage and is not yet available for purchase, id. Also, while the device can detect THC in a 
person’s breath, it is unable to tell how much THC may be in a person’s system, id. This could be 
especially problematic for medical cannabis patients who take forms of cannabis that have low, but 
detectable THC concentrations in their breath. Another issue is how new testing methods should be 
administered so as to ensure privacy rights of employees. Additional legislation is likely necessary to 
protect employee privacy rights as drug-testing technology develops and is an area for further research. 
 86.  See Allen Schaben, In the Age of Legal Marijuana, Many Employers Drop ‘Zero Tolerance’ 
Drug Tests, L.A. TIMES (Apr. 12, 2019), https://www.latimes.com/business/la-fi-marijuana-drug-test-
hiring-20190412-story.html [http://perma.cc/CT3C-5HT9]. 
 87.  Dan Hyman, When the Law Says Using Marijuana is O.K., But the Boss Disagrees, N.Y.
TIMES (July 19, 2019), https://www.nytimes.com/2019/07/19/business/marijuana-employer-drug-
tests.html [http://perma.cc/U6DU-WG9W]. 
 88.  See id.
 89.  Ross v. Ragingwire Telecomm., Inc., 174 P.3d 200, 203 (Cal. 2008). 
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military service.90 Due to his injuries, Ross’s physician recommended that 
and certified Ross to consume cannabis pursuant to California’s Compas-
sionate Use Act of 1996 (“CUA”), a California law that allows the use of 
cannabis for medical purposes.91 In 2001, Ross was offered a job with Rag-
ingwire Telecommunications, but the offer was contingent on his passing a 
pre-employment drug test.92 Ross consented to the test and was soon in-
formed that he had failed due to testing positive for cannabis use.93 Ross 
presented the employer with a copy of his physician’s certification, but was 
told that he was terminated due to the positive test result regardless of the 
certification.94 Ross filed a suit against Ragingwire, alleging his discharge 
was unlawful under the California Fair Employment and Housing Act 
(“FEHA”) and against public policy.95 The lower courts held that Ross 
“could not state a cause of action against his employer for disability-based 
discrimination under the FEHA or for wrongful termination in violation of 
public policy.”96 On appeal, the California Supreme Court upheld the lower 
courts by holding that an employee is not protected from termination due to 
a positive drug test result even if the employee is protected from state crim-
inal prosecution under the CUA.97 The court reasoned that “[n]othing in the 
Act’s text or history indicates the voters intended to articulate any policy 
requiring employers to accommodate marijuana use by employees. Because 
the Act articulates no such policy, to read the FEHA in light of the CUA 
leads to no different result.”98 In addition, the court dismissed Ross’s ar-
gument that his termination was against public policy regarding his right to 
“submit to lawful medical treatment,” holding that the employer defendant 
was not required to accommodate Ross’s cannabis use since Ross’s right to 
refuse medical treatment was not implicated by the adverse employment 
action.99
In 2010, in Emerald Steel Fabricators Inc. v. Bureau of Lab. And In-
dustries, the Oregon Supreme Court handed down a similar decision, re-
versing the Oregon Court of Appeals by concluding that the employer in 
question, Emerald Steel Fabricators, had not discriminated when it fired an 
 90.  Id.
 91.  Ragingwire, 174 P.3d at 204. 
 92.  Id. at 203. 
 93.  Id.
 94.  Id.
 95.  Id.
 96.  Id. at 202. 
 97.  Id. at 209. 
 98.  Id. at 208. 
 99.  Id. at 209. 
2020] PRIVACY RIGHTS F MEDICAL CANNABIS PATIENTS 765 
employee for failing a drug test.100 The employee was a temporary worker 
for Emerald Steel and was being considered for permanent employment; 
however, he was required to submit to a drug test that included screening 
for cannabis as a condition to the permanent offer.101 The employee re-
vealed to his supervisor that he was a certified medical cannabis patient 
licensed under the Oregon Medical Marijuana Act (“OMMA”), but was 
still terminated because of his positive cannabis test result.102 The court 
noted that the OMMA only protects registered Oregon cannabis patients 
from state criminal prosecution, not adverse employment actions, therefore, 
the employer was not obligated to accommodate the employee’s disability 
under ORS 659A.112, the Oregon statute prohibiting disability discrimina-
tion.103 The court’s decision was based on Oregon statute, ORS 659A.124, 
which states that the “protections of ORS 659A.112 ([e]mployment dis-
crimination) do not apply to any employee who is currently engaging in the 
illegal use of drugs if the employer takes action based on that conduct.”104
The court reasoned that use of medical cannabis, even though legal under 
Oregon state law, was an “illegal use of drugs” under the federally preemp-
tive CSA.105 The result of the court’s decision is ominous for medical can-
nabis patients in Oregon without amendatory legislative action, as it means 
that employers may terminate an employee for failing a cannabis drug test 
even if the employee has a valid medical cannabis card issued by the state. 
In Colorado, one of the most progressive states when it comes to le-
galized cannabis,106 there is additional cause for concern for medical can-
nabis patients who are employed or who are seeking employment, 
considering the 2013 decision in Coats v. Dish Network, L.L.C.107 In Coats,
Brandon Coats, a quadriplegic, had been issued a medical cannabis card as 
permitted by an amendment to the Colorado state constitution and was 
legally, under Colorado state law, permitted to purchase and use cannabis 
to alleviate his medical condition.108 While Coats contended that he was 
never under the influence of cannabis at work, and never used it at work, he 
 100.  Emerald Steel Fabricators, Inc. v. Bureau of Lab. and Indus., 230 P.3d 518, 520 (Or. 2010). 
 101.  Id. at 520-21. 
 102.  Id.
 103.  Id. at 521. 
 104.  Id. at 524. 
 105.  Id. at 521. 
 106.  Robert McCoppin, Recreational Marijuana Has Been Legal in Colorado for Years. What Can 
Illinois Learn Before Its Residents Start Firing Up?, CHI. TRIB. (Mar. 21, 2019, 6:45 AM), 
https://www.chicagotribune.com/news/ct-met-colorado-marijuana-legalization-lessons-for-illinois-
20190312-story.html [http://perma.cc/R4CN-W5F6]. 
 107.  Coats v. Dish Network, LLC, 350 P.3d 849 (Colo. 2015). 
 108.  Id. at 850. 
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was terminated from his job at Dish Network after testing positive for can-
nabis during a random employment drug screening.109 Coats claimed that 
he was protected under state law from the “unlawful prohibition of legal 
activities as a condition of employment,” citing a Colorado statute.110 The 
question for the court was whether medical cannabis use should be consid-
ered “lawful activity” as interpreted by the text of the Colorado Lawful 
Activities Statute.111 The Colorado Supreme Court concluded that it was 
not.112 The court analyzed the relevant text of the statute, which states that 
“[i]t shall be a discriminatory or unfair employment practice for an em-
ployer to terminate the employment of any employee due to that employ-
ee’s engaging in any lawful activity off the premises of the employer 
during nonworking hours.”113 For the court, the issue turned on the majori-
ty’s strict interpretation of the word “lawful” as it appeared in the statute, 
determining that there was “no legislative intent to extend employment 
protection to those engaged in activities that violate federal law.”114 The 
court further noted that “while the [Lawful Activities] statute promotes a 
‘hands-off’ policy for a broad range of off-the-job employee behavior, it 
still maintains the larger balance between employer and employee rights 
reflected in Colorado’s at-will employment.”115
California, Oregon, and Colorado are not the only states where suits 
have been brought by employees terminated for failing drug tests even 
though state law permitted them to consume cannabis with a valid medical 
recommendation and certification.116 However, there is some hope that 
state courts are moving away from ceding to onerous federal law when it 
comes to medical cannabis use in the employment context.117 For example, 
in New Mexico, an employee sued his employer because the employer 
refused to pay for his medical cannabis under the New Mexico Worker’s 
Compensation Act (“WCA”).118 While the employer argued that paying for 
the employee’s medical cannabis would be a federal crime, the court disa-
 109.  Id. at 850-51. 
 110.  See COLO. REV. STAT. ANN. § 24-34-402.5 (West 2007). 
 111.  Coats v. Dish Network, LLC, 303 P.3d 147, 148 (Colo. App. 2013), aff’d 350 P.3d 849 (Colo. 
2015). 
 112.  Coats, 350 P.3d at 852. 
 113.  Id.
 114.  Coats, 303 P.3d at 151, aff’d 350 P.3d 849 (Colo. 2015). 
 115.  Id.
 116.  See Casias v. Wal-Mart Stores, Inc., 695 F.3d 428, 431 (6th Cir. 2012). 
 117.  See Braska v. Challenge Mfg. Co., 861 N.W. 2d 289 (Mich. Ct. App. 2014); Maez v. Riley 
Indus., 347 P. 3d 732 (N.M. Ct. App. 2015); Lewis v. Am. Gen. Media, 355 P. 3d 850 (N.M. Ct. App. 
2015). 
 118.  Vialpando v. Ben’s Auto. Servs. 331 P.3d 975, 976 (N.M. Ct. App. 2014). 
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greed and sided with the employee, holding that the medical cannabis was 
“reasonable and necessary for the worker’s treatment” and therefore he was 
protected under the WCA.119 The court explained that whether cannabis 
was considered a prescription drug or a controlled substance for purposes 
of the WCA was irrelevant since medical cannabis “requires the functional 
equivalent of a prescription—certification to the program.”120 While court 
decisions are important regarding the nexus of cannabis and employment 
law, well-drafted legislation that protects privacy rights of medical canna-
bis patients in the workplace while ensuring employers are able to maintain 
a safe working environment is essential to sound public policy. Achieving 
this balance is legislative in foundation, and state legislators should consid-
er and question the essence of the employment relationship as part of a 
larger process of determining appropriate and necessary legal safeguards 
regarding privacy rights and drug-testing. 
III. EXPERIMENTING WITH STATUTORY SOLUTIONS AND
LEGISLATION AT THE STATE LEVEL
A. Undermining the At-Will Employment Doctrine as an Option to 
Protect Medical Cannabis Patients from Adverse Employment Actions 
To counter state court decisions such as Coats, Ragingwire, and Em-
erald Steel, perhaps what is truly needed is a radical reconstruction of the 
common-law regime apropos of the at-will employment doctrine. Through-
out most of the United States,121 the default rule when it comes to establish-
ing or terminating an employer-employee relationship is the “at-will” 
employment doctrine.122 What this means, on one hand, is, essentially, that 
an employee is free to quit his or her job at any time and for any reason. 
While this sounds like a given, considering a person cannot be forced to 
work at a job based on the anti-slavery language found in the Thirteenth 
Amendment of the United States Constitution,123 it is a general “right to 
contract” argument that is propagated by those in favor of the at-will em-
 119.  Id. at 978. 
 120.  Id. at 979. 
 121.  One exception is Montana, which has a provision for termination for “just cause.” See Fre-
quently Asked Questions, MONT. DEP’T LAB. & INDUSTRY, http://dli.mt.gov/resources/faq 
[http://perma.cc/852Z-Q4VF] (last visited Mar. 12, 2020).  
 122.  For an in-depth examination of the common-law history and economic theories behind the at-
will employment doctrine, see Matthew T. Bodie, The Best Way Out Is Always Through: Changing the 
Employment-at-Will Default Rule to Protect Personal Autonomy, 2017 U. ILL. L. REV. 223 (2017). 
 123.  The Thirteenth Amendment states: “Neither slavery nor involuntary servitude, except as a 
punishment for crime whereof the party shall have been duly convicted, shall exist within the United 
States, or any place subject to their jurisdiction.” U.S. Const. amend. XIII. 
768 CHICAGO-KENT LAW REVIEW [Vol 95:3 
ployment doctrine that underpins the law, not necessarily a constitutional 
one.124 Just as employees are free to end the employment relationship at 
any time for any reason, the at-will employment relationship gives employ-
ers the same, reciprocal rights. Yet, in such a situation—under the default 
rule—employers generally have most of the bargaining power, even in a 
good economy. 
Such uneven bargaining power effectively bestows upon an employ-
er—barring a retaliation or discrimination claim under Title VII, the Amer-
icans with Disabilities Act, the Age Discrimination in Employment Act, or 
other similar state or federal law—the arbitrary right to terminate an em-
ployee for any reason or no reason at all.125 Beyond discrimination claims, 
one of the few exceptions to the at-will default rule is when an employee is 
covered under a collective bargaining agreement with a union or an em-
ployment contract provision that takes precedence over the at-will default, 
including a salient clause that provides that the employee can be fired only 
for “just cause.”126
Largely due to the potential disenfranchisement and other adverse ef-
fects on employees, who could theoretically have a job one day and not the 
next based on some superficial whim of an employer, the at-will employ-
ment doctrine has been criticized by many, even those within the business 
community.127 In regards to cannabis, employers may have a legitimate 
concern for occupational safety when it comes to cannabis use just as they 
may with other intoxicants like alcohol, even if technically legal under state 
law. However, from a public policy and public health perspective, it seems 
unreasonable to limit a medical patient from using medication recommend-
ed by a doctor and sanctioned by state law if it has no measurable adverse 
effect on their work or on the business of their employer. It is highly un-
likely that any law or collective-bargaining agreement will protect an em-
 124.  The National Conference of State Legislatures states that “reasons given for our retention of 
the at-will presumption include respect for freedom of contract, employer deference, and the belief that 
both employers and employees favor an at-will employment relationship over job security.” At-Will 
Employment—Overview, NCSL (Apr. 15, 2008), http://www.ncsl.org/research/labor-and-
employment/at-will-employment-overview.aspx [http://perma.cc/FNH5-XJFA] (last visited Mar. 12, 
2020). 
 125.  There are other limited exceptions to the employment-at-will doctrine, depending on the state. 
See Charles J. Muhl, The Employment-at-Will Doctrine: Three Major Exceptions, MONTHLY LAB. REV.
(2001), https://www.bls.gov/opub/mlr/2001/01/art1full.pdf [http://perma.cc/FNK8-SZYZ]. 
 126.  For a comprehensive list of exceptions, see id. 
 127.  Liz Ryan, a contributor for Forbes.com, has suggested that at-will employment hurts business, 
because “it keeps working people focused on behaviors that will preserve their employment status, at 
the expense of airing ideas and issues whose open discussion would be in the best interests of their 
employers.” Liz Ryan, How At-Will Employment Hurts Business, FORBES (May 1, 2014), 
https://www.forbes.com/sites/lizryan/2014/05/01/how-at-will-employment-hurts-
business/#73d5425934d5 [http://perma.cc/CJ3W-5LM2]. 
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ployee from an adverse employment action when the employee shows up to 
work clearly intoxicated.128 But when it comes to cannabis use outside of 
work, especially for medical use, as the late self-help author and cannabis 
advocate Peter McWilliams would say, it “ain’t nobody’s business if you 
do.”129
What if, however, the at-will employment default rule was changed to 
allow for a carve-out that would protect the personal autonomy of workers 
who are not otherwise protected by union representation or a well-crafted 
employment contract?130 The at-will employment rule could be modified to 
allow for a “personal-autonomy presumption.”131 Such a presumption 
would assume that employers and employees have a fairly-bargained for 
“contractual” relationship, in which they agree not to “base decisions af-
fecting the contractual relationship on factors that take place outside of that 
relationship.”132 This revised default rule may result in employers and em-
ployees better communicating about expectations regarding off-duty behav-
ior through a more firm contractual relationship than currently exists under 
the at-will employment regime.133 Employers could bargain for certain 
provisions making exceptions for serious criminal acts that might occur 
outside of the contractual relationship, such as fraud or domestic violence. 
Importantly, however, contractual bargaining would be the underpinning of 
the employment relationship rather than arbitrary decision-making favoring 
employers. 
While modifying or undermining the at-will employment doctrine 
may sound like a promising route for protecting employee privacy rights, 
there are likely serious problems with implementing such changes. For one, 
such a radical change will face steep resistance from the employer lobby, 
probably more so than legislative restrictions on an employer’s zero-
tolerance drug policy. Depending on the state, legislators would likely be 
under enormous pressure from employer groups opposed to modifying the 
at-will doctrine status quo. Second, employees may not have adequate bar-
gaining power even with a modified at-will scenario, absent union repre-
 128.  The arbitrator in the case of an employee (represented by a union) fired for testing positive for 
cannabis found that, even though the employee was a medical cannabis cardholder, “it does not mean 
he has permission to report for work under its influence.” Labor Arbitration Decision, 2012 BNA LA 
Supp. 149225, at *5 (Brodsky, Arb.). 
 129.  See MCWILLIAMS, supra note 27. 
 130.  Bodie, supra note 122, at 226. 
 131.  Id. at 262. 
 132.  Id. at 264. 
 133.  Id. at 264-65. 
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sentation. With shrinking private sector union enrollment nationally,134
increased employee bargaining power is unlikely in the near future. Third, 
when it comes to cannabis and employment drug testing, without effective 
state legislation, employers may point to the strict scheduling language of 
the federal CSA that essentially forbids any use of cannabis, medical or 
otherwise.135 Indeed, the latter of these limitations on changing the at-will 
employment regime is likely to be especially problematic for employees as 
the language in many state “lawful activity” statutes are unclear as to what 
kind of non-work activities are protected.136 This was one of the key issues 
for the court in Coats, where the court’s decision relied on the fact that the 
plaintiff’s medical use of cannabis was not “legal” under controlling feder-
al law and the personal autonomy language in the Colorado statute did not 
specifically protect employees who consumed cannabis.137 Given these 
problems with undermining or modifying the well-established at-will em-
ployment doctrine, it may be an easier task to push for de-scheduling can-
nabis at the federal level. However, given the current polity is unlikely to 
support such a move in the near future, there may be other statutory solu-
tions that states can and have implemented in the interim that would protect 
employees who are also medical cannabis patients from adverse employ-
ment actions and invasive drug testing. 
B. Crafting Statutes that Specifically Protect Medical Cannabis Pa-
tients is Necessary in Light of Changing State Laws Legalizing Cannabis 
Based on a survey by the California chapter of the National Organiza-
tion for Marijuana Legalization (“NORML”), since the passage of Prop. 64, 
which legalized the use of medical cannabis for qualified patients in Cali-
fornia, some 30% of those polled in the survey mentioned they had either 
been refused employment or fired from their job after having tested posi-
tive for cannabis.138 As of 2019, a total of eleven states, including Arizona, 
Arkansas, Delaware, Connecticut, Illinois, Rhode Island, Minnesota, Neva-
da, New York, Pennsylvania, and Maine, have crafted statutes that attempt 
 134.  See Barry T. Hirsch & David Macpherson, The Shrinking American Labor Union, N.Y.
TIMES (Feb. 7, 2015), https://www.nytimes.com/2015/02/08/business/the-shrinking-american-labor-
union.html [http://perma.cc/UZG3-W774]. 
135.  See Drug Scheduling, DEA, https://www.dea.gov/drug-scheduling [http://perma.cc/7NLG-
4PFH] (last visited Mar. 12, 2020). 
 136.  Bodie, supra note 122, at 254. 
 137.  See 350 P.3d 849, 853 (Colo. 2015). 
 138.  Chris Roberts, Why Legal Cannabis Can Still Get You Fired, LEAFLY (Aug. 28, 2018), 
https://www.leafly.com/news/politics/labor-day-blues-why-legal-cannabis-can-still-get-you-fired 
[http://perma.cc/7JLQ-WN7C]. 
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to protect the rights of medical cannabis patients in the employment context 
to some degree.139 In some cases, the protections do not come from the 
medical cannabis acts, but rather through acts tied to legalizing recreational 
cannabis.140 Yet, most of these state statutes are limited in their protection 
of employee rights, as they do not necessarily compel employers to ac-
commodate medical cannabis patients in the workplace.141 This essentially 
means that if a certified medical cannabis patient is found to have used 
cannabis on the job (as determined by drug-testing), the patient-employee 
could be subject to termination or other adverse employment action.142 In 
some states, if an employee has a job classification that is considered “safe-
ty designated,” the statutory protections are nonexistent.143 Therefore, 
many employees are still under the threat of losing their jobs and may be 
hard-pressed to find another one when drug testing is the policy. 
Despite the decisions in Coats, Ragingwire and Emerald Steel, courts 
may be more favorable toward employees where the relevant state laws are 
more specific in their protections. For example, in September 2018, a Con-
necticut federal district court found in favor of an employee who had been 
denied employment after having failed a pre-employment drug test.144 The 
statute at issue in the case was the anti-discrimination provision of the 
Connecticut Palliative Use of Marijuana Act (“PUMA”), which states that 
“unless required by federal law or required to obtain funding . . . No em-
ployer may refuse to hire a person or may discharge, penalize or threaten 
an employee solely on the basis of such person’s or employee’s status as a 
qualifying patient . . . .”145 The plaintiff claimed that her doctors had rec-
ommended the use of cannabis to alleviate symptoms of PTSD and so in-
formed her employer about her status as a registered medical cannabis 
patient.146 However, the employer refused to hire her after she tested posi-
tive for cannabis during a pre-employment drug test.147 The employer ar-
gued that it was exempt from PUMA because of its status as a federal 
 139.  See State Laws Protecting Medical Marijuana Patients’ Employment Rights, CAL. NORML,
http://www.canorml.org/state_laws_protecting_medical_marijuana_patients_employment_rights 
[http://perma.cc/GCJ8-Q89Z] (last visited Mar. 12, 2020). 
 140.  For example, Illinois’ employment protection provisions are found under the CRTA. See
Cannabis Regulation and Tax Act, H.B., 1438, 2019 Gen. Assemb. 101st Sess. (Ill. 2019), § 10-50(a). 
 141.  Roberts, supra note 138. 
 142.  Id.
 143.  Id.
 144.  Noffsinger v. SSC Niantic Operating Co., LLC, 338 F. Supp. 3d 78 (D. Conn. 2018). 
 145.  CONN. GEN. STAT. § 21a-40p(b)(3) (2012), https://www.cga.ct.gov/current/pub/ 
chap_420f.htm#sec_21a-408p [http://perma.cc/Z7VS-SHLT]. 
 146.  Noffsinger, 338 F. Supp. 3d at 82.  
 147.  Id.
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government contractor and was instead required to comply with the 
preemptive federal funding provisions of the Drug-Free Workplace Act 
(“DFWA”).148 The court sided with the employee: “The DFWA does not 
require drug testing . . . nor does the DFWA prohibit federal contractors 
from employing someone who uses illegal drugs outside the workplace in 
accordance with a program approved by state law.”149 While the court’s 
decision is not binding,150 it suggests courts may lean toward protecting the 
privacy rights of employees when it comes to drug testing medical cannabis 
patients—at least in states with carefully crafted statutes. 
Other states are taking note and implementing their own restrictions 
on drug testing for cannabis. In Maine, as of February 1, 2018, protections 
for employees who consume cannabis outside of work have been extended 
for adult-use in addition to medical use,151 but the application of the law is 
less clear. Maine’s law attempts to provide some employee protections in 
that it prohibits employers from disciplining employees for cannabis use 
outside of work, although the law does allow employers to “discipline em-
ployees who are under the influence of marijuana in the workplace.”152 An 
employee may be drug tested, but if the employee fails the drug test he or 
she is not necessarily subject to an adverse employment action; rather, the 
burden is on the employer to prove that the employee was actually under 
the influence while at work.153 Julie Rabiowitz, the state’s Department of 
Labor director of policy explains how Maine’s policy is different from 
other states: 
If the Legislature does not take action to provide clear, consistent, easy 
to follow regulations, Maine risks more employers leaving the state. 
Let’s stop thinking of drug testing as something punitive. Rather, it in-
centivizes employees, especially those in recovery, to stay clean, and 
promotes a safer work environment for all workers.154
 148.  Id. at 84. 
 149.  Id.
 150.  Jennifer Mora & Anthony Califano, Federal Judge Rules that Employer Violated Connecticut 
Law by Refusing to Hire Medical Marijuana User, BLUNT TRUTH (Sept. 12, 2018), 
https://www.blunttruthlaw.com/2018/09/federal-judge-rules-that-employer-violated-connecticut-law-
by-refusing-to-hire-medical-marijuana-user/#more-2496 [http://perma.cc/GN3T-ERGF]. 
 151.  Melinda Caterine, Dale Deitchler, Nancy Delogu & Jeff Dilger, Maine Employers Must 
Ignore Off-Work Marijuana Use, Cease Testing Applicants, LITTLER (Jan. 30, 2018), 
https://www.littler.com/publication-press/publication/maine-employers-must-ignore-work-marijuana-
use-cease-testing [http://perma.cc/P7G5-F85A]. 
 152.  ME. STAT. TIT. 28-B, § 112(3)(2018), http://legislature.maine.gov/statutes/28-B/title28-
Bsec112.html [http://perma.cc/T9G5-6B6Z]. 
 153.  Penelope Overton, Extra Burden Expected in 2018 for Maine Employers who Test for Mari-
juana, PRESS HERALD (July 24, 2017), https://www.pressherald.com/2017/07/24/maine-employers-
shouldnt-test-for-marijuana-without-changes-to-state-law-official-says/ [http://perma.cc/Z8QD-PY8W]. 
154.  Id.
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Law firms that represent employers suggest that “employers with law-
ful workplace drug-testing policies implemented in accordance with Maine 
law will need to assess compliance approaches, risks and risk tolerance in 
connection with marijuana policy prohibitions, continued marijuana testing 
and adverse action, if any, based on verified confirmed marijuana test re-
sults.”155 This seems to suggest that employers are likely to face challenges 
in implementing drug testing policies because taking adverse employment 
action against an employee would take more than a drug test result. How-
ever, it may be just as challenging for a medical cannabis patient to show 
that their cannabis use was outside of work if an employer claims they are 
under the influence at work and the employee tests positive. Thus, an em-
ployee who uses cannabis outside of work may still be at risk for an ad-
verse employment action. For these reasons, Maine’s law attempts to strike 
a balance, but may be too ambiguous in application and may not go far 
enough in protecting employee privacy rights. 
C. Illinois: Limited Privacy Protections for Medical Cannabis Pa-
tients in Light of Otherwise Progressive State Law 
As of January 1, 2020, residents of Illinois over the age of twenty-one 
will legally be able to purchase and consume a limited amount of cannabis 
for recreational use under the CRTA, making Illinois the 11th state to legal-
ize cannabis for recreational use.156 The new law will also make it easier 
for people previously convicted of cannabis possession to have their crimi-
nal records expunged.157 In addition, Illinois has taken the initiative to pro-
vide opportunities to those considered “social equity applicants,” with the 
intention of giving assistance to those looking to start a cannabis business 
in communities considered “hardest hit by the war on marijuana,” accord-
ing to Illinois governor J.B. Pritzker.158 In addition to signing the CRTA 
into law, Pritzker also made the existing medical cannabis program perma-
nent, expanding it to encompass several new qualifying conditions, includ-
ing chronic pain, migraines, anorexia nervosa, and osteoarthritis.159
 155.  Caterine et al., supra note 151. 
 156.  Illinois Weed Legalization Guide, ABC 7 CHI. (Sept. 30, 2019), 
https://abc7chicago.com/politics/weed-legalization-guide/5337346/ [http://perma.cc/J76T-S6SY]. 
 157.  Id.
 158.  Illinois Releases ‘Disproportionately Impacted Areas’ Map For Social Equity Cannabis 
Program Applicants, ABC 7 CHIC. (Sept. 30, 2019), https://abc7chicago.com/business/illinois-releases-
map-for-social-equity-cannabis-program-applicants/5579443/ [http://perma.cc/D6VY-42G6]. 
 159.  Tom Schuba, Pritzker Makes Medical Marijuana Program Permanent, Adds List of New 
Conditions, CHI. SUN TIMES (Aug. 12, 2019), 
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Medical cannabis patients will also enjoy enhanced benefits under the new 
law, including an exemption from the taxes levied on recreational cannabis 
and the option to grow up to five plants in their homes.160 In totality, the 
new Illinois cannabis laws are likely some of the most progressive in the 
country. However, the new laws continue to lack adequate protection for 
certified medical cannabis patients when it comes to employer drug-testing, 
not unlike Maine’s recreational cannabis law. At the very least, the text of 
the CRTA related to employment policies regarding cannabis is vague 
enough to concern employees and employers alike.161
Section 10-50 of the CRTA clearly states “[n]othing in this Act shall 
prohibit an employer from adopting reasonable zero tolerance or drug free 
workplace policies, or employment policies concerning drug testing . . . 
provided that the policy is applied in a nondiscriminatory manner.”162 Fur-
thermore, “Nothing in the Act shall limit or prevent an employer from dis-
ciplining an employee or terminating employment of an employee for 
violating an employer’s employment policies or workplace drug policy.”163
Based on this language, it is likely that blanket pre-employment drug-
testing that tests all applicants equally will be seen as reasonable and non-
discriminatory, regardless of an applicant’s status as a certified medical 
cannabis patient under state law. There are no exceptions in the CRTA for 
certified medical cannabis patients that would exempt them from pre-
employment drug-testing if an employer decides to maintain such a poli-
cy.164
In addition, employers are given specific protections under Section 
10-50(e) of the CRTA against employee actions if the employer had a 
“good faith belief that an employee used or possessed cannabis in the em-
ployer’s workplace or while performing the employee’s job duties or while 
on call in violation of the employer’s employment policies.”165 Section 10-
50(d) articulates a set of examples by which an employer may determine 
whether an employee is “impaired or under the influence of cannabis” 
https://chicago.suntimes.com/cannabis/2019/8/12/20802391/pritzker-makes-medical-marijuana-
program-permanent-adds-list-new-conditions [http://perma.cc/5NVA-8H96]. 
 160.  See Illinois Weed Legalization Guide, supra note 159. 
 161.  Steven Pearlman, Illinois’ Hazy New Law Legalizing Recreational Use Of Marijuana,
FORBES (Aug. 15, 2019), https://www.forbes.com/sites/stevenpearlman/2019/08/15/illinois-hazy-new-
law-legalizing-recreational-use-of-marijuana/#2caf4694511a [http://perma.cc/PUN8-XVWA]. 
 162.  Cannabis Regulation and Tax Act, H.B. 1438, 2019 Gen. Assemb. 101st Sess. (Ill. 2019) § 
10-50(a), https://www2.illinois.gov/IISNews/19996-Adult_Use_Cannabis_Legislation.pdf 
[http://perma.cc/G5NZ-YLUQ].  
 163.  Id. at 10-50(d). 
 164.  Id.
 165.  Id. at 10-50(e). 
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while acting as agent of the employer.166 However, although prior to taking 
disciplinary action against an employee, the employer “must afford the 
employee a reasonable opportunity to contest the basis of the determina-
tion,”167 there is nothing to suggest that certified medical cannabis patients 
would have adequate standing to challenge such a determination based 
solely on having a valid medical cannabis certification. Therefore, medical 
cannabis patients in Illinois are likely not exempt from any employer drug 
testing unless the employer’s drug testing is considered unreasonable or 
discriminatory. If an employer maintains a policy that treats all applicants 
and employees generally the same when it comes to drug testing and the 
testing is standardized, it is unlikely that employees will be able to bring a 
claim based on one of these required elements under § 10-50 of the CRTA. 
Importantly, the CRTA continues to enforce these employer rights under 
the Illinois Compassionate Use of Medical Cannabis Pilot Program Act, 
which likewise does not provide medical cannabis patients with an exemp-
tion from an employer-mandated drug test.168 As Illinois legalizes cannabis 
for recreational use, medical cannabis patients appear to be left out in the 
cold in terms of employment protection. Amendatory legislation to the 
CRTA should be drafted to better protect medical cannabis patients in Illi-
nois from adverse employment actions based on an employer’s cannabis 
drug testing so that employees do not need to choose between their medi-
cine and employment opportunities. 
IV. CONCLUSION
Medical patients who are certified under state laws to legally consume 
cannabis for the treatment of a myriad of medical issues often face a diffi-
cult choice when it comes to employment, (1) either use medical cannabis 
and risk failing a drug test or, (2) go without their medication and suffer. 
Such a choice is absurd, illogical, and against public policy. One solution 
would be to remove cannabis from the restrictive Schedule I classification 
under the CSA, in the hope that most employment drug testing for cannabis 
would abate. But absent such successful action at the federal level, state 
legislatures should alternatively craft laws that protect certified medical 
cannabis patients from adverse employment actions when the adverse em-
ployment actions are based on overbroad drug testing methods. Rather than 
 166.  Id. at 10-50(d). 
 167.  Id.
 168.  Illinois Recreational Marijuana Bill Awaiting Gov. Pritzker’s Signature: Workplace Consid-
erations, CLARK BAIRD SMITH, LLC (June 4, 2019), https://www.cbslawyers.com/marijuana 
[http://perma.cc/JHM9-JNNV]. 
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defer to federal law regarding cannabis, where applicable, courts in states 
where cannabis is legal should abide by the intent of the state legislature 
and state constituents by protecting certified medical cannabis patients 
against unreasonable adverse employment actions and privacy invasion. 
However, effective and unambiguous state legislation regarding medical 
cannabis and employment drug testing is the foundation for ensuring fair-
ness and balance in the courts. Therefore, it is up to state legislatures and 
local governments to solve the problem by amending existing laws or en-
suring protections are in place as states prepare to legalize cannabis. 
